It has been suggested for several diseases that extreme PGS risk confers a similar magnitude of increased risk as the presence of Mendelian pathogenic variants (for example, familial hypercholesterolemia for coronary artery disease, and BRCA1 or BRCA2 for breast cancer12,19,20). This evidence concerns the gene BRCA1 and familial hypercholesterolemia.